Sangamo Therapeutics, Inc. (LON:0R1D)
0.5436
+0.0037 (0.69%)
At close: Jul 2, 2025
Sangamo Therapeutics Employees
Sangamo Therapeutics had 183 employees as of December 31, 2024. The number of employees decreased by 222 or -54.81% compared to the previous year.
Employees
183
Change (1Y)
-222
Growth (1Y)
-54.81%
Revenue / Employee
269.65K GBP
Profits / Employee
-336.03K GBP
Market Cap
91.67M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 94,300 |
GSK plc | 68,629 |
Haleon | 24,561 |
Smith & Nephew | 17,349 |
ConvaTec Group | 10,489 |
Hikma Pharmaceuticals | 9,500 |
HUTCHMED (China) | 1,811 |
Oxford Nanopore Technologies | 1,382 |
Sangamo Therapeutics News
- 10 days ago - Sangamo Therapeutics Announces Positive Topline Results From Registrational STAAR Study in Fabry Disease - Business Wire
- 7 weeks ago - Sangamo Therapeutics prices $23M securities offering - Seeking Alpha
- 7 weeks ago - Sangamo Therapeutics misses top-line and bottom-line estimates; reaffirms FY25 outlook - Seeking Alpha
- 7 weeks ago - Sangamo Therapeutics, Inc. (SGMO) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Sangamo Therapeutics, Inc. 2025 Q1 - Results - Earnings Call Presentation - Seeking Alpha
- 7 weeks ago - Sangamo Therapeutics Reports Recent Business Highlights and First Quarter 2025 Financial Results - Benzinga
- 7 weeks ago - Sangamo Therapeutics Reports Recent Business Highlights and First Quarter 2025 Financial Results - Business Wire
- 7 weeks ago - Sangamo Therapeutics Announces Pricing of $23.0 Million Underwritten Offering - Business Wire